Furthermore, the current study revealed that GDF-15 levels were positively correlated with age, diabetes status, and NT-proBNP levels in HER2-positive breast cancer patients, which might explain the predictive value of GDF-15 for cardiotoxicity risk to some extent. The gene discussed is ERBB2; the disease is breast cancer.